Silverback Therapeutics Inc SBTX Valuation Ratios and Share Stats

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Silverback Therapeutics Inc (SBTX)
Silverback Therapeutics Inc (SBTX) Financials

Silverback Therapeutics Inc (SBTX)

5.87

0.00

( 0.00% )

Updated: 19:00:00

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-127.629	-110.974	-16.054	-24.573	-11.28	-21.128
Return on Equity (%)	100.517	51.127	-20.331	-25.687	-11.823	-21.589
Return on Invested Capital (%)	-210.007	-426.191	-17.492	-28.38	-13.694	-27.005
Operating Margin (%)	N/A	N/A	N/A	N/A	-2635.41	-181216.667
Net Profit Margin (%)	N/A	N/A	N/A	N/A	-2635.41	-181216.667
Book Value Per Share	27.697	-8.438	11.034	9.043	7.605	2.404
Earnings Per Share	-26.756	-36.095	-0.949	-2.579	-0.967	-0.566
Cash Per Share	30.685	15.024	11.14	7.321	5.867	0.739
Working Capital Per Share	23.796	-11.142	10.981	7.106	7.587	2.389
Operating Profit Per Share	N/A	N/A	N/A	N/A	0.037	N/A
EBIT Per Share	-26.756	-36.095	-0.949	-2.579	-0.967	-0.566
EBITDA Per Share	-26.756	-36.095	-0.949	-2.579	-0.967	-0.566
Free Cash Flow Per Share	-26.804	-36.77	-0.941	-2.562	-0.97	-0.565

Liquidity Ratios

Year End December 30 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	657k	664k	34.7M	34.7M	N/A	N/A

Key Stats and Ratios

Year End December 30 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-74805	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	-74805	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	563.5M
Price to Earnings Ratio	-19.04
Price to Sales Ratio	35.93k
Price to Cash Ratio	14.58
Price to Book Ratio	4.48
Dividend Yield	-

Share Statistics

Shares Outstanding	96M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Silverback Therapeutics

Delayed Upgrade Clock